186 related articles for article (PubMed ID: 12079737)
1. Chemotherapy of canine leishmaniosis.
Baneth G; Shaw SE
Vet Parasitol; 2002 Jul; 106(4):315-24. PubMed ID: 12079737
[TBL] [Abstract][Full Text] [Related]
2. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
3. Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
Medkour H; Bitam I; Laidoudi Y; Lafri I; Lounas A; Hamidat HK; Mekroud A; Varloud M; Davoust B; Mediannikov O
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008947. PubMed ID: 33338041
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial.
Corpas-López V; Merino-Espinosa G; Acedo-Sánchez C; Díaz-Sáez V; Navarro-Moll MC; Morillas-Márquez F; Martín-Sánchez J
Vet Res Commun; 2018 Jun; 42(2):121-130. PubMed ID: 29453596
[TBL] [Abstract][Full Text] [Related]
6. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
Pasa S; Toz SO; Voyvoda H; Ozbel Y
Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
[TBL] [Abstract][Full Text] [Related]
7. Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
Saridomichelakis MN; Xenoulis PG; Chatzis MK; Kasabalis D; Steiner JM; Suchodolski JS; Petanides T
Vet Parasitol; 2013 Oct; 197(1-2):22-8. PubMed ID: 23685064
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis.
Oliva G; Gradoni L; Cortese L; Orsini S; Ciaramella P; Scalone A; de Luna R; Persechino A
Ann Trop Med Parasitol; 1998 Mar; 92(2):165-71. PubMed ID: 9625912
[TBL] [Abstract][Full Text] [Related]
9. Failure of buparvaquone (Butalex) in the treatment of canine visceral leishmaniosis.
Vexenat JA; Croft SL; Furtado Campos JH; Miles MA
Vet Parasitol; 1998 May; 77(1):71-3. PubMed ID: 9652385
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.
Manna L; Vitale F; Reale S; Caracappa S; Pavone LM; Morte RD; Cringoli G; Staiano N; Gravino AE
Vet Parasitol; 2004 Nov; 125(3-4):251-62. PubMed ID: 15482882
[TBL] [Abstract][Full Text] [Related]
11. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M
Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753
[TBL] [Abstract][Full Text] [Related]
12. Short term impacts of meglumine antimoniate treatment on kidney function in dogs with clinical leishmaniosis.
Daza González MA; Miró G; Fermín Rodríguez M; Rupérez Noguer C; Fragío Arnold C
Res Vet Sci; 2019 Oct; 126():131-138. PubMed ID: 31491669
[TBL] [Abstract][Full Text] [Related]
13. Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy.
de Jong MK; Rappoldt A; Broere F; Piek CJ
Parasit Vectors; 2023 May; 16(1):163. PubMed ID: 37189181
[TBL] [Abstract][Full Text] [Related]
14. The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
Cortese L; Pelagalli A; Piantedosi D; Mastellone V; Di Loria A; Lombardi P; Ciaramella P; Avallone L
Vet J; 2008 Sep; 177(3):405-10. PubMed ID: 17629526
[TBL] [Abstract][Full Text] [Related]
15. Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol.
Gonçalves G; Campos MP; Gonçalves AS; Medeiros LCS; Figueiredo FB
Parasit Vectors; 2021 Dec; 14(1):599. PubMed ID: 34886876
[TBL] [Abstract][Full Text] [Related]
16. Tongue nodules in canine leishmaniosis--a case report.
Viegas C; Requicha J; Albuquerque C; Sargo T; Machado J; Dias I; Pires MA; Campino L; Cardoso L
Parasit Vectors; 2012 Jun; 5():120. PubMed ID: 22704596
[TBL] [Abstract][Full Text] [Related]
17. Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy.
Alvar J; Molina R; San Andrés M; Tesouro M; Nieto J; Vitutia M; González F; San Andrés MD; Boggio J; Rodriguez F
Ann Trop Med Parasitol; 1994 Aug; 88(4):371-8. PubMed ID: 7979624
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment.
Martínez-Subiela S; Bernal LJ; Cerón JJ
Am J Vet Res; 2003 Aug; 64(8):1021-6. PubMed ID: 12926596
[TBL] [Abstract][Full Text] [Related]
19. Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis.
Segarra S; Miró G; Montoya A; Pardo-Marín L; Boqué N; Ferrer L; Cerón J
Vet Parasitol; 2017 May; 239():50-56. PubMed ID: 28495197
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate.
Schettini DA; Costa Val AP; Souza LF; Demicheli C; Rocha OG; Melo MN; Michalick MS; Frézard F
Braz J Med Biol Res; 2005 Dec; 38(12):1879-83. PubMed ID: 16302103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
